Abstract
Objective Remote or mobile consulting (mConsulting) is being promoted to strengthen health systems, deliver universal health coverage and facilitate safe clinical communication during COVID-19 and beyond. We explored whether mConsulting is a viable option for communities with minimal resources in low- and middle-income countries (LMICs).
Methods We reviewed evidence published since 2018 about mConsulting in LMICs and undertook a scoping study (pre-COVID) in two rural settings (Pakistan, Tanzania) and five urban slums (Kenya, Nigeria, Bangladesh), using policy/document review, secondary analysis of survey data (from the urban sites), and thematic analysis of interviews/workshops with community members, healthcare workers, digital/telecommunications experts, mConsulting providers, local and national decision-makers. Project advisory groups guided the study in each country.
Results We reviewed five empirical studies and seven reviews, analysed data from 5,219 urban slum households and engaged with 419 stakeholders in rural and urban sites. Regulatory frameworks are available in each country. mConsulting services are operating through provider platforms (n=5-17) and, at community-level, some direct experience of mConsulting with healthcare workers using their own phones was reported - for emergencies, advice and care follow-up. Stakeholder willingness was high, provided challenges are addressed in technology, infrastructure, data security, confidentiality, acceptability and health system integration. mConsulting can reduce affordability barriers and facilitate care-seeking practices.
Conclusions There are indications of readiness for mConsulting in communities with minimal resources. However, wider system strengthening is needed to bolster referrals, specialist services, laboratories and supply-chains to fully realise the continuity of care and responsiveness that mConsulting services offer, particularly during/beyond COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a foundation grant from the Health Systems Research Initiative with funding from the UK Department for International Development, the UK Economic and Social Research Council, the UK Medical Research Council and Wellcome (Grant no. MR/S012729/1). SP and MA (Global Challenges Research Fund Fellowship No. IAS/32013/19) gratefully acknowledge support provided by the Warwick Institute of Advanced Study. FG receives funding as South Africa Research Chair in Health Policy and Systems from the National Research Foundation, South Africa. RJL is supported by the NIHR Applied Research Collaboration (ARC) West Midlands, UK.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants provided informed consent to participate before taking part in the study. Ethical approval was obtained from: AMREF Health Africa Ethics and Scientific Review Committee (AMREF-ESRC P719/2019) Biomedical and Scientific Research Ethics Sub-Committee, University of Warwick, United Kingdom (REGO-2019-2343) National Institute for Medical Research, Tanzania (NIMR/HQ/R.8a/Vol.IX/3044) Pakistan: Ethics Review Committee ERC (No: 2019-1040-3484) Research Ethics Committee of the Oyo State Ministry of Health (AD13/479/1193). The Institutional Review Board of the Institute of Health Economics (IHE-IRB), which is approved by Federalwide Assurance (FWA), Bangladesh (No. FWA00026031) We analysed secondary data obtained through the NIHR Global Health Research Unit on Improving Health in Slums. This work was granted full ethical approval by: AMREF Health Africa Ethics and Scientific Review Committee (AMREFESRC P440/2018) Bangladesh Medical Research Council BMRC/NREC/2016-2019/759). Biomedical and Scientific Research Ethics Sub-Committee, University of Warwick (REGO-2017-2043 AM01), Ministry of Health, Lagos State Government (LSMH/2695/11/259), Research Ethics Committee of the Oyo State Ministry of Health, Nigeria (AD13/479/657) National Bioethics Committee Pakistan (4-87/NBC-298/18/RDC3530)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No additional data are available.
